Literature DB >> 20643700

Non-LDL-related dyslipidaemia and coronary risk: a case-control study.

Gerd Assmann1, Paul Cullen, Helmut Schulte.   

Abstract

To assess the non-LDL-C-related dyslipidaemia risk of MI, 823 men aged 23 to 65 with a first MI were compared with 823 MI-free PROCAM controls matched for sex, age, smoking, DM, BP and LDL-C. Overall, the odds of MI in men with HDL-C < 1.15 mmol/L were 2.6 times those of men with HDL-C >or= 1.15 mmol/L, and the odds of MI in men with triglycerides >or= 1.71 mmol/L were 1.4 times those of men with lower triglycerides. If LDL-C was < 2.58 mmol/L, relative MI odds attributed to HDL-C < 1.15 mmol/L increased to 3.4, while relative odds attributed to triglycerides >or= 1.71 mmol/L increased to 2.6; men in this LDL category with HDL-C < 1.15 mmol/L and/or triglycerides >or= 1.71 mmol/L displayed an MI odds ratio of 5.0. MI risk associated with low HDL-C and/or high triglycerides is substantial, particularly if LDL-C is low.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643700     DOI: 10.1177/1479164110372640

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  8 in total

1.  Residual cardiovascular risk in secondary prevention.

Authors:  Alberto Zambon
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 2.  The role of triglycerides in atherosclerosis.

Authors:  Beatriz G Talayero; Frank M Sacks
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

Review 3.  A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile.

Authors:  Wiraphol Phimarn; Kittisak Wichaiyo; Khuntawan Silpsavikul; Bunleu Sungthong; Kritsanee Saramunee
Journal:  Eur J Nutr       Date:  2016-03-14       Impact factor: 5.614

Review 4.  Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

Review 5.  Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.

Authors:  M John Chapman; Henry N Ginsberg; Pierre Amarenco; Felicita Andreotti; Jan Borén; Alberico L Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Børge G Nordestgaard; Kausik K Ray; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen; Gerald F Watts
Journal:  Eur Heart J       Date:  2011-04-29       Impact factor: 29.983

6.  Characterization of lipid parameters in diabetic and non-diabetic atherosclerotic patients.

Authors:  Fatima Ali; Hassan Jamil; Sanam Saiqa Anwar; Nadia Wajid
Journal:  J Geriatr Cardiol       Date:  2015-01       Impact factor: 3.327

7.  Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study.

Authors:  Salgaonkar V Jaywant; A K Singh; Mundkur S Prabhu; R Ranjan
Journal:  Indian Heart J       Date:  2016-02-28

Review 8.  Residual macrovascular risk in 2013: what have we learned?

Authors:  Jean-Charles Fruchart; Jean Davignon; Michel P Hermans; Khalid Al-Rubeaan; Pierre Amarenco; Gerd Assmann; Philip Barter; John Betteridge; Eric Bruckert; Ada Cuevas; Michel Farnier; Ele Ferrannini; Paola Fioretto; Jacques Genest; Henry N Ginsberg; Antonio M Gotto; Dayi Hu; Takashi Kadowaki; Tatsuhiko Kodama; Michel Krempf; Yuji Matsuzawa; Jesús Millán Núñez-Cortés; Carlos Calvo Monfil; Hisao Ogawa; Jorge Plutzky; Daniel J Rader; Shaukat Sadikot; Raul D Santos; Evgeny Shlyakhto; Piyamitr Sritara; Rody Sy; Alan Tall; Chee Eng Tan; Lale Tokgözoğlu; Peter P Toth; Paul Valensi; Christoph Wanner; Alberto Zambon; Junren Zhu; Paul Zimmet
Journal:  Cardiovasc Diabetol       Date:  2014-01-24       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.